New drug combo could slow kidney failure in rare genetic disease
Disease control
Ongoing
This study tests whether two common drugs—dapagliflozin and spironolactone—can reduce protein in the urine of adults with Alport syndrome, a genetic kidney disease that often leads to kidney failure. About 34 participants will try each drug alone and then together, adding them to…
Phase: PHASE4 • Sponsor: Stefan Lujinschi • Aim: Disease control
Last updated May 01, 2026 15:57 UTC